KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

BioNTech SE (BNTX) Debt to Equity (2018 - 2021)

BioNTech SE's Debt to Equity history spans 4 years, with the latest figure at $0.12 for Q4 2021.

  • On a quarterly basis, Debt to Equity fell 34.28% to $0.12 in Q4 2021 year-over-year; TTM through Dec 2021 was $0.12, a 34.28% decrease, with the full-year FY2021 number at $0.12, down 34.28% from a year prior.
  • Debt to Equity hit $0.12 in Q4 2021 for BioNTech SE, down from $0.18 in the prior quarter.
  • Over the last five years, Debt to Equity for BNTX hit a ceiling of $0.23 in Q4 2018 and a floor of $0.12 in Q4 2021.
  • Historically, Debt to Equity has averaged $0.17 across 4 years, with a median of $0.17 in 2020.
  • Biggest five-year swings in Debt to Equity: grew 8.98% in 2020 and later crashed 34.28% in 2021.
  • Tracing BNTX's Debt to Equity over 4 years: stood at $0.23 in 2018, then crashed by 31.37% to $0.16 in 2019, then grew by 8.98% to $0.18 in 2020, then crashed by 34.28% to $0.12 in 2021.
  • Business Quant data shows Debt to Equity for BNTX at $0.12 in Q4 2021, $0.18 in Q4 2020, and $0.16 in Q4 2019.